ConductScience.org, home

Paper16282986

Phoenix-ampho outperforms PG13 as retroviral packaging cells to transduce human T cells with tumor-specific receptors: implications for clinical immunogene therapy of cancer.

Lamers CH and 5 others. Cancer Gene Ther, 2006. Cited by 31 papers, by iCite.

Cite this record

ConductScience Library. Phoenix-ampho outperforms PG13 as retroviral packaging cells to transduce human T cells with tumor-specific receptors: implications for clinical immunogene therapy of cancer. Papers, record 16282986. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16282986

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Phoenix-ampho outperforms PG13 as retroviral packaging cells to transduce human T cells with tumor-specific receptors: implications for clinical immunogene therapy of cancer.
PubMed
Journal
Cancer Gene Ther
PubMed
Year
2006
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
31
iCite
Relative citation ratio, by iCite
0.56
iCite
Revised in PubMed
2026-10-10
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lamers CHC H J
2Willemsen RAR A
3van Elzakker PP
4van Krimpen BAB A
5Gratama JWJ W
6Debets RR

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, NeoplasmMajor topic
Carbonic AnhydrasesMajor topic
Immunoglobulin Variable RegionMajor topic
Kidney NeoplasmsMajor topic
Receptors, ImmunologicMajor topic
T-LymphocytesMajor topic
Transduction, GeneticMajor topic
Virus AssemblyMajor topic
Carbonic Anhydrase IX
Cell Line
Cells, Cultured
Combined Modality Therapy
Cytotoxicity, Immunologic
Genetic Therapy
Humans
Immunotherapy, Adoptive
Retroviridae
Single-Chain Antibodies

Source PubMed

Download CSV of topics

References11

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112574392Peptide fine specificity of anti-glycoprotein 100 CTL is preserved following transfer of engineered TCR alpha beta genes into primary human T lymphocytes.J Immunol2003https://conductscience.org/library/papers/12574392PubMed
210356257Differential inhibition of retrovirus transduction by proteoglycans and free glycosaminoglycans.Biotechnol Prog1999https://conductscience.org/library/papers/10356257PubMed
318432682Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems.Curr Protoc Immunol2001https://conductscience.org/library/papers/18432682PubMed
49973498Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers.J Immunol1999https://conductscience.org/library/papers/9973498PubMed
512881303Dose finding with retroviral vectors: correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population.Blood2003https://conductscience.org/library/papers/12881303PubMed
610680014Functional balance between T cell chimeric receptor density and tumor associated antigen density: CTL mediated cytolysis and lymphokine production.Gene Ther2000https://conductscience.org/library/papers/10680014PubMed
712082462Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer.Cancer Gene Ther2002https://conductscience.org/library/papers/12082462PubMed
815471217Adoptive immuno-gene therapy of cancer with single chain antibody [scFv(Ig)] gene modified T lymphocytes.J Biol Regul Homeost Agents2004https://conductscience.org/library/papers/15471217PubMed
99930320A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes.Gene Ther1998https://conductscience.org/library/papers/9930320PubMed
1012669036Safety of retroviral gene marking with a truncated NGF receptor.Nat Med2003https://conductscience.org/library/papers/12669036PubMed
1114741772Chance or necessity? Insertional mutagenesis in gene therapy and its consequences.Mol Ther2004https://conductscience.org/library/papers/14741772PubMed

Download CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.

PMIDTitleJournalYearIn PapersSource
40764385Functional avidity of anti-B7H3 CAR-T constructs predicts antigen density thresholds for triggering effector function.Nat Commun2025https://conductscience.org/library/papers/40764385PubMed
39172012TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer.Cancer Discov2024https://conductscience.org/library/papers/39172012PubMed
38673757Car T Cells in Solid Tumors: Overcoming Obstacles.Int J Mol Sci2024https://conductscience.org/library/papers/38673757PubMed
35622329Gene Engineering T Cells with T-Cell Receptor for Adoptive Therapy.Methods Mol Biol2022https://conductscience.org/library/papers/35622329PubMed
29350274T lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expression.Acta Neuropathol2018https://conductscience.org/library/papers/29350274PubMed
27096098Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient.J Immunother Cancer2016https://conductscience.org/library/papers/27096098PubMed
26824221Functional cloning of a gp100-reactive T-cell receptor from vitiligo patient skin.Pigment Cell Melanoma Res2016https://conductscience.org/library/papers/26824221PubMed
25423330T cell receptor-engineered T cells to treat solid tumors: T cell processing toward optimal T cell fitness.Hum Gene Ther Methods2014https://conductscience.org/library/papers/25423330PubMed
24027572An Altered gp100 Peptide Ligand with Decreased Binding by TCR and CD8α Dissects T Cell Cytotoxicity from Production of Cytokines and Activation of NFAT.Front Immunol2013https://conductscience.org/library/papers/24027572PubMed
23423337Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T cells: clinical evaluation and management of on-target toxicity.Mol Ther2013https://conductscience.org/library/papers/23423337PubMed
22871260Magnetic-activated cell sorting of TCR-engineered T cells, using tCD34 as a gene marker, but not peptide-MHC multimers, results in significant numbers of functional CD4+ and CD8+ T cells.Hum Gene Ther Methods2012https://conductscience.org/library/papers/22871260PubMed
22400038TCR gene transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 epitopes as melanoma-specific immune targets.Clin Dev Immunol2012https://conductscience.org/library/papers/22400038PubMed
18202714Retroviral vectors for clinical immunogene therapy are stable for up to 9 years.Cancer Gene Ther2008https://conductscience.org/library/papers/18202714PubMed
17479266Gene-modified T cells for adoptive immunotherapy of renal cell cancer maintain transgene-specific immune functions in vivo.Cancer Immunol Immunother2007https://conductscience.org/library/papers/17479266PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CA9768PubTator's text mininghttps://conductscience.org/library/genes/768NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16282986

GET https://conductscience.org/api/papers/v1/16282986/authors